ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 239 filers reported holding ARRAY BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $36,865,000 | +41.9% | 795,712 | -25.3% | 0.68% | +35.6% |
| Q1 2019 | $25,982,000 | +9.8% | 1,065,712 | -35.8% | 0.50% | +5.5% |
| Q4 2018 | $23,664,000 | -45.3% | 1,660,631 | -41.7% | 0.48% | -10.3% |
| Q3 2018 | $43,260,000 | +159.6% | 2,846,000 | +186.6% | 0.53% | +62.7% |
| Q2 2018 | $16,663,000 | -53.7% | 993,000 | -55.0% | 0.33% | -12.8% |
| Q1 2018 | $36,002,000 | +172.3% | 2,206,000 | +113.6% | 0.38% | +138.9% |
| Q4 2017 | $13,222,000 | +89.3% | 1,033,000 | +81.9% | 0.16% | +78.4% |
| Q3 2017 | $6,986,000 | +73.9% | 568,000 | +18.3% | 0.09% | -13.7% |
| Q2 2017 | $4,018,000 | +164.3% | 480,000 | +182.4% | 0.10% | +142.9% |
| Q1 2017 | $1,520,000 | -3.9% | 170,000 | -5.6% | 0.04% | -12.5% |
| Q4 2016 | $1,582,000 | +80.2% | 180,000 | +38.5% | 0.05% | +84.6% |
| Q3 2016 | $878,000 | – | 130,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
| APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
| BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
| First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
| SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
| GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
| Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
| X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
| FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |